Please login to the form below

Not currently logged in
Email:
Password:

Pharma approval

This page shows the latest Pharma approval news and features for those working in and with pharma, biotech and healthcare.

Sun Pharma passes milestone with novel psoriasis drug approval

Sun Pharma passes milestone with novel psoriasis drug approval

Sun Pharma passes milestone with novel psoriasis drug approval. Ilumya will treat adults with a moderate-to-severe form of the skin condition. ... With the approval of Ilumya and our long-standing commitment in dermatology, we are focused on making a

Latest news

  • Mylan gets first biosimilar Herceptin OK from FDA Mylan gets first biosimilar Herceptin OK from FDA

    Mylan has become the first pharma company to win US approval for a biosimilar of Roche’s big-selling cancer antibody Herceptin. ... Mylan said in a statement Ogivri is the first biosimilar in its collaboration with Biocon to get US approval, and while

  • Novartis gets EU nod for leukaemia drug Rydapt Novartis gets EU nod for leukaemia drug Rydapt

    Novartis gets EU nod for leukaemia drug Rydapt. The FLT3 inhibitor adds to its US approval in AML. ... Novartis could however see competition in future from FLT3 inhibitors in development atand Arog Pharma.

  • Merck mulls sale of consumer health division Merck mulls sale of consumer health division

    The news comes a few days after Merck picked up an important new approval for its pharma division in Europe, with the EMA clearing Mavenclad (cladribine) for the treatment of ... for Merkel cell carcinoma (MCC), which was recommended for approval in the

  • Celgene, Agios get FDA OK for leukaemia drug Idhifa Celgene, Agios get FDA OK for leukaemia drug Idhifa

    Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a specific genetic mutation. ... It has launched the drug immediately on approval, becoming the first new drug specifically approved for AML by

  • Samsung Bioepis wins CHMP nod for second Humira biosimilar Samsung Bioepis wins CHMP nod for second Humira biosimilar

    Novartis' CDK4/6 inhibitor Kisqali (ribociclib) got the nod for the treatment of locally advanced or metastatic breast cancer - three months after getting FDA approval in breast cancer - while Eusa Pharma ... Tivozanib - originally developed by Aveo

More from news
Approximately 2 fully matching, plus 69 partially matching documents found.

Latest Intelligence

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    And then there is the problem of public opinion. “We have a ridiculously low approval rating for an industry that saves so many lives, ”remarked the president of one of the ... With a net approval rating of minus 23, pharma sits only marginally above

  • Europe vs the US: New drug product approvals Europe vs the US: New drug product approvals

    Big pharma continues to dominate the approval statistics, with oncology being the most common therapy area represented. ... Oncology and big pharma dominate the approval statistics. Looking at the therapeutic areas, the busiest by far was oncology.

  • Why don’t big pharma brands win creative awards? Why don’t big pharma brands win creative awards?

    We asked some senior people in pharma companies and agencies for their opinions about this paradox. ... Big pharma decision-making discourages creativity. “ The approval process makes it harder than ever to get good work through.” - Creative Director.

  • A tailored approach to the BRIC markets A tailored approach to the BRIC markets

    Pharma's emerging market strategies must therefore be tailored to suit local needs. ... But the deals came at a price for pharma: a condition of the approval is that the companies - which include Pfizer and B Braun - commit to the continued production of

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • vector pharma

    vector pharma. vector pharma specialises in the provision of close strategic regulatory support to innovative small to medium-size development-phase pharma companies seeking product approval within the EU. ... vector pharma works very closely with

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics